Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-054827

Options or other derivatives

  • Chief Financial Officer acquired 470,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Buck Paul · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2013-10-08 Grant or award : show line 1 in the form Option to Purchase +470,000 470,000 D
Loading xslF345X03/v357191_form4.xml…